Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.71 |
| ▸ | MGLL | Q99685 | 4/20 | 0.67 |
| ▸ | FAAH | O00519 | 2/20 | 0.67 |
| ▸ | GSK3A | P49840 | 2/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3034487 | 0.83 | PTGS1 (1.00) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL146412 | 0.82 | MGLL (1.00) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL12905303 | 0.77 | HDAC1 (0.68) | KMT2ALMNAADRA1DADRA1AADRA1B | |
| SCHEMBL4800190 | 0.76 | MGLL (0.78) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL9610843 | 0.76 | MGLL (1.00) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL4804503 | 0.76 | MGLL (0.78) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL8950019 | 0.76 | MGLL (0.86) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL21215698 | 0.76 | MGLL (0.86) | PTGS1PTGS2MGLLFAAHGSK3A | |
| SCHEMBL4550732 | 0.75 | HDAC6 (0.54) | PTGS1PTGS2KMT2ALMNAHRH3 | |
| SCHEMBL7218376 | 0.74 | MGLL (0.82) | PTGS1PTGS2MGLLFAAHGSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110104051-A1 | Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-05-05 | — | — | US | disclosed |
| WO-2007126764-A2 | CHEMICALLY MODIFIED VIRAL CAPSIDS AS TARGETED DELIVERY VECTORS FOR DIAGNOSTIC AND THERAPEUTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104051-A1 | Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents | HAVCR2, CALR, EEA1 | PTGS1 4461/4885PTGS2 4375/4885MGLL 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.